Inventor
EIZENBERG ORLY
IL14 patents
⚠️ This page may combine multiple inventors who share the name “EIZENBERG ORLY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOKINE THERAPEUTICS LTD
8 patentsUS10646465B2May 12, 2020
Small molecules against cancer
BIOKINE THERAPEUTICS LTD6 citations82
US9493557B2Nov 15, 2016
Chemokine binding polypeptides for treating autoimmunity and inflammation
BIOKINE THERAPEUTICS LTD7 citations82
US11129824B2Sep 28, 2021
Small molecules for inhibiting chemokine activity and/or cancer cells growth
BIOKINE THERAPEUTICS LTD4 citations71
US10959979B2Mar 30, 2021
Small molecules against cancer
BIOKINE THERAPEUTICS LTD0 citations60
US8383769B2Feb 26, 2013
Peptides for inhibiting chemokine binding to chemokine receptors
BIOKINE THERAPEUTICS LTD3 citations60
US8039440B2Oct 18, 2011
Peptides for inhibiting chemokine binding to chemokine receptors
BIOKINE THERAPEUTICS LTD2 citations60
US7488717B2Feb 10, 2009
Methods of inhibiting chemokine binding to chemokine receptors
BIOKINE THERAPEUTICS LTD2 citations60
US8796227B2Aug 5, 2014
Peptides for inhibiting chemokine binding to chemokine receptors
BIOKINE THERAPEUTICS LTD0 citations49
ALONBIO LTD
4 patentsUS11261159B2Mar 1, 2022
Small molecules for treating cancer, inhibiting chemokine activity and/or inducing cell death
ALONBIO LTD4 citations69
US12233057B2Feb 25, 2025
Small molecules for inhibiting chemokine activity and/or cancer cells growth
ALONBIO LTD0 citations58
US12202803B2Jan 21, 2025
Small molecules for treating cancer, inhibiting chemokine activity and/or inducing cell death
ALONBIO LTD0 citations58
US11780814B2Oct 10, 2023
Small molecules for treating cancer, inhibiting chemokine activity and/or inducing cell death
ALONBIO LTD1 citations58